Shenzhen Refond Optoelectronics Co.,Ltd.

SZSE:300241 Stock Report

Market Cap: CN¥3.8b

Shenzhen Refond OptoelectronicsLtd Balance Sheet Health

Financial Health criteria checks 5/6

Shenzhen Refond OptoelectronicsLtd has a total shareholder equity of CN¥2.1B and total debt of CN¥323.8M, which brings its debt-to-equity ratio to 15.1%. Its total assets and total liabilities are CN¥3.3B and CN¥1.2B respectively. Shenzhen Refond OptoelectronicsLtd's EBIT is CN¥3.7M making its interest coverage ratio -0.2. It has cash and short-term investments of CN¥280.3M.

Key information

15.1%

Debt to equity ratio

CN¥323.80m

Debt

Interest coverage ratio-0.2x
CashCN¥280.30m
EquityCN¥2.15b
Total liabilitiesCN¥1.19b
Total assetsCN¥3.34b

Recent financial health updates

No updates

Recent updates

Shenzhen Refond Optoelectronics Co.,Ltd. (SZSE:300241) Surges 51% Yet Its Low P/S Is No Reason For Excitement

Oct 08
Shenzhen Refond Optoelectronics Co.,Ltd. (SZSE:300241) Surges 51% Yet Its Low P/S Is No Reason For Excitement

Shenzhen Refond Optoelectronics Co.,Ltd.'s (SZSE:300241) Revenues Are Not Doing Enough For Some Investors

Aug 20
Shenzhen Refond Optoelectronics Co.,Ltd.'s (SZSE:300241) Revenues Are Not Doing Enough For Some Investors

Shenzhen Refond Optoelectronics Co.,Ltd.'s (SZSE:300241) Shares Bounce 28% But Its Business Still Trails The Industry

May 21
Shenzhen Refond Optoelectronics Co.,Ltd.'s (SZSE:300241) Shares Bounce 28% But Its Business Still Trails The Industry

Financial Position Analysis

Short Term Liabilities: 300241's short term assets (CN¥1.4B) exceed its short term liabilities (CN¥1.1B).

Long Term Liabilities: 300241's short term assets (CN¥1.4B) exceed its long term liabilities (CN¥96.3M).


Debt to Equity History and Analysis

Debt Level: 300241's net debt to equity ratio (2%) is considered satisfactory.

Reducing Debt: 300241's debt to equity ratio has increased from 6.6% to 15.1% over the past 5 years.

Debt Coverage: 300241's debt is well covered by operating cash flow (61.4%).

Interest Coverage: 300241 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies